Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Residual mutations in epigenetic modifiers are associated with poor prognosis and high relapse rate in Acute Myeloid Leukemia

Xin Yan, Chunhua Song, Zheng Ge

Blood (2025) 146 (Supplement 1): 1740.

https://doi.org/10.1182/blood-2025-1740

Published: 2025

Journal Articles

High efficacy of azacitidine combined with lenalidomide in TP53 mutation-positive and other high-risk myelodysplastic neoplasms

Xin Yan, Chunhua Song, Zheng Ge

Blood (2025) 146 (Supplement 1): 2082.

https://doi.org/10.1182/blood-2025-2082

Published: 2025

Journal Articles

Clinical study reveals the high efficacy and well-tolerance of venetoclax combined with homoharringtonine, azacitidine, and cytarabine in newly diagnosed AML

Xin Yan, Yanqing Huang, Chunhua Song, Zheng Ge

Blood (2025) 146 (Supplement 1): 5224.

https://doi.org/10.1182/blood-2025-5224

Published: 2025

Journal Articles

Targeting the casein kinase II /ikaros axis sensitizes TKI activity by suppression of GLUT1 expression and glycolysis in ph+ ALL

Linyao Zhang, Qi Han, Huimin Xiang, Chunhua Song, Zheng Ge

Blood (2025) 146 (Supplement 1): 3305.

https://doi.org/10.1182/blood-2025-3305

Published: 2025

Journal Articles

Synergistic efficacy of EZH2 inhibitor combined with new flavonoid derivatives in AML patient-derived xenograft mouse models

Chan Yang, Qinglong Guo, Hui Hui, Hui Li, Chunhua Song, Zheng Ge

Blood (2025) 146 (Supplement 1): 3277.

https://doi.org/10.1182/blood-2025-3277

Published: 2025

Journal Articles

Targeting hedgehog signaling/KL4-dependent M2 macrophage polarization for treatment of chronic graft-versus-host diseases and tissue fibrosis

Chunhua Song, Benjamin Kaffenberger, Chelsea Steiner, Dayong Wu, Yi Zhang, Xiaopei Huang, Yiping Yang

Blood (2025) 146 (Supplement 1): 583.

https://doi.org/10.1182/blood-2025-583

Published: 2025

Journal Articles

Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL

Qi Han, Yan Gu, Huimin Xiang, Linyao Zhang, Yan Wang, Chan Yang, Jun Li, Chelsea Steiner, Rosa Lapalombella, Jennifer A. Woyach, Yiping Yang, Sinisa Dovat, Chunhua Song, Zheng Ge

Blood (2025) 145 (13): 1407–1421.

https://doi.org/10.1182/blood.2024024130

Published: 2025

Includes: Supplemental data

Journal Articles

Newly-Acquired and Clonally-Increased Mutations in TP53 and RAS Pathways Promote Progressive Disease and Leukemic Transformation in Patients with Myelodysplatic Neoplasms

Xin Yan, Sr., Yulu Tian, Yan Gu, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 3224.

https://doi.org/10.1182/blood-2024-206378

Published: 2024

Journal Articles

Targeted Therapy with CX4945 Biomimetic Nanodrug Delivery System for High-Risk B-Cell Acute Lymphoblastic Leukemia

Yan Wang, Fei Wang, Haoan Wu, Qi Han, Yu Zhang, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 2788.

https://doi.org/10.1182/blood-2024-202461

Published: 2024

Journal Articles

Synergistic Effect of EZH2 Inhibitor Dznep and Flavonoid GL-V9 in AML through Inhibition Hells and Induction of DNA Damage

Chan Yang, Qinglong Guo, Hui Hui, Hui Li, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 4145.

https://doi.org/10.1182/blood-2024-202407

Published: 2024

Journal Articles

Dynamic Changes of Key Gene Mutations in the Disease Course of Patients with Chronic Myelomonocytic Leukemia

Xin Yan, Sr., Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 6743.

https://doi.org/10.1182/blood-2024-206853

Published: 2024

Journal Articles

A Study to Assess the Efficacy of Venetoclax Combined with Homoharringtonine and Azacitidine in De Novo Acute Myeloid Leukemia

Yanqing Huang, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 6071.

https://doi.org/10.1182/blood-2024-205100

Published: 2024

Journal Articles

Microbiological Analysis of Bloodstream Infections in Patients with Acute Leukemia and the Association with Prognosis

Rui Ge, Yanqing Huang, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 5978.

https://doi.org/10.1182/blood-2024-207346

Published: 2024

Journal Articles

Synergistic Effect of CK2 Inhibitor CX-4945 with HDACi Chidamide in B-Cell Acute Lymphoblastic Leukemia By Downregulating TCL1A Expression

Huimin Xiang, Qi Han, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 5764.

https://doi.org/10.1182/blood-2024-202484

Published: 2024

Journal Articles

Dynamic Changes of Genetic Mutations in AML Patients from Diagnosis to Complete Remission and Relapse

Xin Yan, Sr., Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 6108.

https://doi.org/10.1182/blood-2024-207314

Published: 2024

Journal Articles

A Novel Natural Derivative GL-V9 Inducing Mitotic Catastrophe and Displaying a Synergistic Anti-Tumor Effect with EZH2 Inhibitor in Acute Myeloid Leukemia

Chan Yang, Qinglong Guo, Hui Hui, Hui Li, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 7137.

https://doi.org/10.1182/blood-2023-186141

Published: 2023

Journal Articles

HDAC Inhibitor Synergizes with GL-V9, a Derivative of Wogonin, to Suppress Acute Myeloid Leukemia By Downregulating ESPL1 and PLK4

Chan Yang, Qinglong Guo, Hui Hui, Hui Li, Siyu Gu, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 5758.

https://doi.org/10.1182/blood-2023-185510

Published: 2023

Journal Articles

Synergistic Effect of CK2 Inhibitor CX-4945 with HDACi Chidamide on Cell Proliferation Arrest and Apoptosis in Acute Myeloid Leukemia

Huimin Xiang, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 6000.

https://doi.org/10.1182/blood-2023-185928

Published: 2023

Journal Articles

Casein Kinase II Inhibitor Sensitizes the Anti-Tumor Effect of EZH2 Inhibitor By Suppressing FOSL1 Expression in Acute Myeloid Leukemia

Chan Yang, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 5996.

https://doi.org/10.1182/blood-2023-185378

Published: 2023

Journal Articles

Azacitidine Combined with Novel Flavonoid Derivative GL-V9 Demonstrated Synergistic Anti-Leukemia Effect in Acute Myeloid Leukemia By Targeting DDIT4/mTOR Signaling

Jun Li, Qinglong Guo, Hui Hui, Hui Li, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 5686.

https://doi.org/10.1182/blood-2023-185714

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Residual mutations in epigenetic modifiers are associated with poor prognosis and high relapse rate in Acute Myeloid Leukemia

High efficacy of azacitidine combined with lenalidomide in TP53 mutation-positive and other high-risk myelodysplastic neoplasms

Clinical study reveals the high efficacy and well-tolerance of venetoclax combined with homoharringtonine, azacitidine, and cytarabine in newly diagnosed AML

Targeting the casein kinase II /ikaros axis sensitizes TKI activity by suppression of GLUT1 expression and glycolysis in ph+ ALL

Synergistic efficacy of EZH2 inhibitor combined with new flavonoid derivatives in AML patient-derived xenograft mouse models

Targeting hedgehog signaling/KL4-dependent M2 macrophage polarization for treatment of chronic graft-versus-host diseases and tissue fibrosis

Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL

Newly-Acquired and Clonally-Increased Mutations in TP53 and RAS Pathways Promote Progressive Disease and Leukemic Transformation in Patients with Myelodysplatic Neoplasms

Targeted Therapy with CX4945 Biomimetic Nanodrug Delivery System for High-Risk B-Cell Acute Lymphoblastic Leukemia

Synergistic Effect of EZH2 Inhibitor Dznep and Flavonoid GL-V9 in AML through Inhibition Hells and Induction of DNA Damage

Dynamic Changes of Key Gene Mutations in the Disease Course of Patients with Chronic Myelomonocytic Leukemia

A Study to Assess the Efficacy of Venetoclax Combined with Homoharringtonine and Azacitidine in De Novo Acute Myeloid Leukemia

Microbiological Analysis of Bloodstream Infections in Patients with Acute Leukemia and the Association with Prognosis

Synergistic Effect of CK2 Inhibitor CX-4945 with HDACi Chidamide in B-Cell Acute Lymphoblastic Leukemia By Downregulating TCL1A Expression

Dynamic Changes of Genetic Mutations in AML Patients from Diagnosis to Complete Remission and Relapse

A Novel Natural Derivative GL-V9 Inducing Mitotic Catastrophe and Displaying a Synergistic Anti-Tumor Effect with EZH2 Inhibitor in Acute Myeloid Leukemia

HDAC Inhibitor Synergizes with GL-V9, a Derivative of Wogonin, to Suppress Acute Myeloid Leukemia By Downregulating ESPL1 and PLK4

Synergistic Effect of CK2 Inhibitor CX-4945 with HDACi Chidamide on Cell Proliferation Arrest and Apoptosis in Acute Myeloid Leukemia

Casein Kinase II Inhibitor Sensitizes the Anti-Tumor Effect of EZH2 Inhibitor By Suppressing FOSL1 Expression in Acute Myeloid Leukemia

Azacitidine Combined with Novel Flavonoid Derivative GL-V9 Demonstrated Synergistic Anti-Leukemia Effect in Acute Myeloid Leukemia By Targeting DDIT4/mTOR Signaling

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only